Description
ROS1 rearrangement as therapeutic marker for Lung Cancer
ROS1 rearrangement as therapeutic marker for Lung Cancer
₹4,522.32 Original price was: ₹4,522.32.₹0.00Current price is: ₹0.00.
ROS1 rearrangement as therapeutic marker for Lung Cancer
ROS1 rearrangement as therapeutic marker for Lung Cancer
APTT Mixing studies identifies the cause for the raised APTT. This could be due to presence of factor deficiency, Lupus anticoagulant, heparin contamination / therapy or deficiency of fibrinogen
APTT Mixing studies identifies the cause for the raised APTT. This could be due to presence of factor deficiency, Lupus anticoagulant, heparin contamination / therapy or deficiency of fibrinogen
Represents the main body reservoir
Represents the main body reservoir
Susceptibily results with MIC values of Linezolid, Trimethoprim / Sulphamethaxole, Ciprofloxacin, Imipenem, Moxifloxacin, Cefepime, Cefoxitin, Augmentin, Amikacin, Ceftriaxone, Doxycycline, Minocycline, Tigecycline, Tobramycin, Clarithromycin
Susceptibily results with MIC values of Linezolid, Trimethoprim / Sulphamethaxole, Ciprofloxacin, Imipenem, Moxifloxacin, Cefepime, Cefoxitin, Augmentin, Amikacin, Ceftriaxone, Doxycycline, Minocycline, Tigecycline, Tobramycin, Clarithromycin
Absolute eosinophil count is increased in allergic or atopic disease, infectious disorders (including parasites), medications, immunologic reactions, skin disorders, pulmonary syndromes, rheumatologic diseases, myeloproliferative neoplasms and secondary to other malignancies.
Absolute eosinophil count is increased in allergic or atopic disease, infectious disorders (including parasites), medications, immunologic reactions, skin disorders, pulmonary syndromes, rheumatologic diseases, myeloproliferative neoplasms and secondary to other malignancies.

Reviews
There are no reviews yet.